Viewing StudyNCT06414681



Ignite Creation Date: 2024-05-19 @ 5:33 PM
Last Modification Date: 2024-10-26 @ 3:29 PM
Study NCT ID: NCT06414681
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-16
First Post: 2024-02-23

Brief Title: Combination of Tagraxofusp With Pacritinib in Patients With Intermediate-1 or Higher Myelofibrosis Who Have Had Prior Therapy With the Approved JAK Inhibitors or in Which Therapy With the Approved JAK Inhibitors is Not Appropriate Contraindicated or Declined
Sponsor: University of Kansas Medical Center
Organization: University of Kansas Medical Center

Conditions & Keywords Data

Conditions:
Name
MyelofibrosisMF
Keywords:
Name View
Myelofibrosis View
MF View
JAK 12 View
Tagraxofusp View
TAG View
Pacritinib View
PAC View
Tagraxofusp with Pacritinib View
Intermediate II Myelofibrosis View
Higher Myelofibrosis View